Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.7.1 instead of v3.7.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T20:18:18.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and navigation. It replaces the usual study content, indicating that access to the study details is blocked.
    Difference
    19%
    Check dated 2026-09-23T20:34:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0. This indicates a refresh or minor update to the page content.
    Difference
    0.1%
    Check dated 2026-09-16T21:40:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6, replacing the previous v3.6.5 in the footer. This appears to be a versioning/metadata update rather than a change to substantive content or features.
    Difference
    0.1%
    Check dated 2026-09-02T17:58:47.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.6.5 replacing the previous v3.6.4, indicating a minor backend or UI update without changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-08-12T18:40:21.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 on the page, signaling a newer revision tag. This is an administrative update to the page rather than a change to study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-22T08:17:43.000Z thumbnail image

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.